These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25204528)

  • 1. [Functional characteristics of macular telangiectasia type 2].
    Heeren TF; Krüger E; Holz FG; Charbel Issa P
    Ophthalmologe; 2014 Sep; 111(9):829-33. PubMed ID: 25204528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2.
    Charbel Issa P; Heeren TF; Kupitz EH; Holz FG; Berendschot TT
    Retina; 2016 Mar; 36(3):524-34. PubMed ID: 26618805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoscopic Vision in Macular Telangiectasia Type 2.
    Müller S; Heeren TFC; Nadal J; Charbel Issa P; Herrmann P; Holz FG; Wabbels BK
    Ophthalmologica; 2019; 241(3):121-129. PubMed ID: 30196286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Vision Loss in Macular Telangiectasia Type 2.
    Heeren TF; Clemons T; Scholl HP; Bird AC; Holz FG; Charbel Issa P
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3905-12. PubMed ID: 26070062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
    Tzaridis S; Friedlander M;
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First symptoms and their age of onset in macular telangiectasia type 2.
    Heeren TF; Holz FG; Charbel Issa P
    Retina; 2014 May; 34(5):916-9. PubMed ID: 24351446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VISUAL FUNCTION CORRELATES OF FOVEAL SLOPE CHANGES ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2.
    Jaisankar D; Raman R; Gondhale H; Chhablani J; Agarwal M
    Retina; 2017 Dec; 37(12):2248-2253. PubMed ID: 27930459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binocular Inhibition of Reading in Macular Telangiectasia Type 2.
    Tzaridis S; Herrmann P; Charbel Issa P; Degli Esposti S; Wagner SK; Fruttiger M; Egan C; Rubin G; Holz FG; Heeren TFC
    Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3835-3841. PubMed ID: 31529080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomographic angiography in type 1 idiopathic macular telangiectasia.
    Pappuru RR; Peguda HK; Dave VP
    Clin Exp Optom; 2018 Jan; 101(1):143-144. PubMed ID: 28295586
    [No Abstract]   [Full Text] [Related]  

  • 10. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chorioretinal anastomosis as a complication of idiopathic macular telangiectasia type 2].
    Levy N; Comet A; Gascon P; Belhada A; Denis D; Matonti F
    J Fr Ophtalmol; 2018 Apr; 41(4):e169-e171. PubMed ID: 29650258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives].
    Holz FG; Heeren TF; Krüger E; Zeimer M; Pauleikhoff D; Charbel Issa P
    Ophthalmologe; 2014 Sep; 111(9):834-8. PubMed ID: 25204529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macular telangiectasia type 2: The international MacTel project].
    Charbel Issa P; Pauleikhoff D; Holz FG
    Ophthalmologe; 2014 Sep; 111(9):817-8. PubMed ID: 25204526
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of vision in idiopathic macular holes with macular microperimetry using the scanning laser ophthalmoscope.
    Sjaarda RN; Frank DA; Glaser BM; Thompson JT; Murphy RP
    Ophthalmology; 1993 Oct; 100(10):1513-8. PubMed ID: 8414412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive changes from idiopathic macular telangiectasia seen with spectral domain optical coherence tomography.
    Fallano KA; Ibrahim M; Nguyen QD; Do DV
    Can J Ophthalmol; 2010 Dec; 45(6):649-50. PubMed ID: 20648067
    [No Abstract]   [Full Text] [Related]  

  • 16. Type 2 idiopathic macular telangiectasia.
    Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
    Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.
    Chew EY; Clemons TE; Jaffe GJ; Johnson CA; Farsiu S; Lad EM; Guymer R; Rosenfeld P; Hubschman JP; Constable I; Wiley H; Singerman LJ; Gillies M; Comer G; Blodi B; Eliott D; Yan J; Bird A; Friedlander M;
    Ophthalmology; 2019 Apr; 126(4):540-549. PubMed ID: 30292541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Fujii GY; De Juan E; Humayun MS; Sunness JS; Chang TS; Rossi JV
    Am J Ophthalmol; 2003 Dec; 136(6):1067-78. PubMed ID: 14644217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual function in patients with idiopathic macular telangiectasia type 1.
    Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Acta Ophthalmol; 2016 Nov; 94(7):e672-e673. PubMed ID: 27230481
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive optics microperimetry and OCT images show preserved function and recovery of cone visibility in macular telangiectasia type 2 retinal lesions.
    Wang Q; Tuten WS; Lujan BJ; Holland J; Bernstein PS; Schwartz SD; Duncan JL; Roorda A
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):778-86. PubMed ID: 25587056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.